| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the University Eye Hospital Lübeck, Lübeck, Germany.
PURPOSE. To identify early vascular changes in choroidal neovascularization (CNV) and in adjacent normal choroid, after photodynamic therapy (PDT).
METHODS. In a prospective study, 40 patients with predominantly classic CNV due to age-related macular degeneration (AMD) were treated with PDT performed with verteporfin. Verteporfin was administered intravenously at a dose of 6 mg/m2 body surface area. A near infrared laser light dose of 50 J/cm2, an irradiance of 600 mW/cm2 and a wavelength of 692 nm was applied. A scanning laser system was used to perform confocal fluorescein angiography (FA) and indocyanine green angiography (ICGA) before treatment and regularly at 5 hours, 1 day, 1 week, and 3 months after PDT. Images were analyzed for CNV size and leakage area as seen by FA and ICGA. Collateral damage within the surrounding choroid was documented based on the hypofluorescence in early- and late-phase ICGA.
RESULTS. No immediate occlusion of the CNV complex was found angiographically, but a dynamic change over time was observed in the early perfusion patterns and late-phase hyper- and hypofluorescence. At 5 hours after treatment, large portions of the CNV lesion were still perfused. One day after PDT, CNV size in early FA and early ICGA reached its minimum, at 0.49 mm2 (15.7%) and 0.78 mm2 (31.1%) of the initial area, respectively. In late-phase FA and ICGA, however, an immediate massive exudation with a continuous increase in hyperfluorescence originated from the CNV and surrounding choroid, with a maximum in leakage area at 1 day. At 1 week PDT-induced exudation slowly resolved. Eyes in 36 patients showed some choroidal hypofluorescence by ICGA before treatment. A progressive increase of the hypofluorescent area surrounding the CNV was observed, which correlated with the size of the laser spot. Maximum hypofluorescence was noted at 1 week with an average size of 11.1 mm2 in early- and late-phase ICGA.
CONCLUSIONS. In contrast to findings in experimental animals, PDT in humans with classic CNV did not induce immediate thrombosis, but primarily caused a breakdown of vascular barriers. A characteristic sequence of vascular changes was observed with early, enhanced leakage from the CNV and normal choroid followed by nonperfusion later. Occlusion of the CNV lesions occurred 1 day after treatment, but closure of the adjacent choroidal vessels proceeded slowly over as long as 1 week.
This article has been cited by other articles:
|
|
 |
|
  C G Kiss, C Simader, S Michels, and U Schmidt-Erfurth Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study Br J Ophthalmol, December 1, 2008; 92(12): 1620 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U Schmidt-Erfurth, S Wolf, and for the PROTECT Study Group Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration Br J Ophthalmol, December 1, 2008; 92(12): 1628 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Parmeggiani, C. Costagliola, D. Gemmati, S. D'Angelo, P. Perri, C. Campa, L. Catozzi, F. Federici, A. Sebastiani, and C. Incorvaia Coagulation Gene Predictors of Photodynamic Therapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3100 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berdugo, R. A. Bejjani, F. Valamanesh, M. Savoldelli, J.-C. Jeanny, D. Blanc, H. Ficheux, A. Scherz, Y. Salomon, D. BenEzra, et al. Evaluation of the New Photosensitizer Stakel (WST-11) for Photodynamic Choroidal Vessel Occlusion in Rabbit and Rat Eyes Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1633 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Weigert, S Michels, S Sacu, A Varga, F Prager, W Geitzenauer, and U Schmidt-Erfurth Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study Br J Ophthalmol, March 1, 2008; 92(3): 356 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tatar, K. Shinoda, E. Kaiserling, G. Pertile, C. Eckardt, A. Mohr, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, and S. Grisanti Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization Arch Ophthalmol, February 1, 2008; 126(2): 193 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. F. Bashshur, A. Schakal, R. N. Hamam, C. P. El Haibi, R. F. Jaafar, and B. N. Noureddin Intravitreal Bevacizumab vs Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration Arch Ophthalmol, October 1, 2007; 125(10): 1357 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, A. Adam, K. Shinoda, T. Eckert, G. B Scharioth, M. Klein, E. Yoeruek, K. U. Bartz-Schmidt, and S. Grisanti Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy Br J Ophthalmol, September 1, 2007; 91(9): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ishikawa, M. Kondo, Y. Ito, M. Kikuchi, H. Nishihara, C.-H. Piao, T. Sugita, and H. Terasaki Correlation between Focal Macular Electroretinograms and Angiographic Findings after Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2254 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanito, S. Kaidzu, and R. E. Anderson Delayed Loss of Cone and Remaining Rod Photoreceptor Cells due to Impairment of Choroidal Circulation after Acute Light Exposure in Rats Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1864 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, K. Shinoda, A. Adam, T. Eckert, C. Eckardt, K. Lucke, C. Deuter, K. U. Bartz-Schmidt, and S. Grisanti Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes Br J Ophthalmol, February 1, 2007; 91(2): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Imai, S Honda, Y Nakanishi, H Yamamoto, Y Tsukahara, and A Negi Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy Br J Ophthalmol, December 1, 2006; 90(12): 1524 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tatar, E. Kaiserling, A. Adam, F. Gelisken, K. Shinoda, M. Volker, B. A. Lafaut, K. U. Bartz-Schmidt, and S. Grisanti Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes. Arch Ophthalmol, June 1, 2006; 124(6): 815 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes, and T. Hasan Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications Clin. Cancer Res., February 1, 2006; 12(3): 917 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Michels, F. Hansmann, W. Geitzenauer, and U. Schmidt-Erfurth Influence of Treatment Parameters on Selectivity of Verteporfin Therapy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 371 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tzekov, T. Lin, K.-M. Zhang, B. Jackson, A. Oyejide, W. Orilla, A. D. Kulkarni, B. D. Kuppermann, L. Wheeler, and J. Burke Ocular Changes after Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Visudyne in Minimally Classic Choroidal Neovascula Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration: 2-Year Results of a Randomized Clinical Trial Arch Ophthalmol, April 1, 2005; 123(4): 448 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ming, P. V. Algvere, A. Odergren, L. Berglin, I. van der Ploeg, S. Seregard, and A. Kvanta Subthreshold Transpupillary Thermotherapy Reduces Experimental Choroidal Neovascularization in the Mouse without Collateral Damage to the Neural Retina Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1969 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, and G. O. H. Naumann Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4473 - 4480. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
